Skip to main content

Table 1 Timeline of the study

From: Radioablation +/− hormonotherapy for prostate cancer oligorecurrences (Radiosa trial): potential of imaging and biology (AIRC IG-22159)

 

Screening

2 weeks within randomization

1 months after end of RT

3 months after end of RT

Every 3 months

12 months after end of RT

Every year

Biochimical relapse

Clinical relapse

Physical examination

x

  

x

 

x

   

PSA/testosterone

x

  

x

x

x

   

GS

x

        

Previous treatments for PCa

x

        

ECOG score

x

        

Comorbidities

x

        

Imaging

x

        

Blood tests (NLR)

 

x

       

Serum and plasma collection

 

x

 

x

    

x

Acute toxicity assessment

  

x

      

Late toxicity assessment

   

x

     

QoL

 

x

 

x

 

x

x

 

x

Cho-PET/TC or RM-WB

       

x

x